NCT04469777View on ClinicalTrials.gov

Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 15, 2020

Study Completion Date

December 30, 2020

Conditions
Optic Neuropathy
Interventions
DRUG

erythropoietin

Systemic erythropoietin injections (eprax 10000 IU subcutaneous twice daily for three days).

Trial Locations (1)

Unknown

Alexandria Faculty of Medicine, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT04469777 - Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy | Biotech Hunter | Biotech Hunter